PUBLISHER: Grand View Research | PRODUCT CODE: 1587431
PUBLISHER: Grand View Research | PRODUCT CODE: 1587431
The global electroretinogram market size is estimated to reach USD 1.15 billion by 2030, expanding at a CAGR of 8.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. The rising demand for early disease diagnosis, constant innovations & development of newer technologies, and the growing geriatric population, which is at risk of developing eye disorders like glaucoma and diabetic retinopathy, are expected to drive the market growth. The eyes being the most sensitive part of the body, ophthalmic procedures are conducted with high accuracy and precision levels. This is the main driving factor for the growth of the market. Moreover, increasing disposable income levels, rising awareness about early disease diagnosis, and increased government funds for ophthalmological R&D are supporting the market growth.
Electroretinogram is also used for evaluating the efficiency of eye safety procedures. The market exhibited marginally positive growth during and after the COVID-19 pandemic. According to the study published on PubMed Central by NCBI, COVID-19 can affect the retinal level, such as affecting retinal vasculature. Moreover, few cases related to retinal side effects were reported after the COVID-19 vaccination. Hence, to diagnose and monitor the health of the retina and other related eye disorders, electroretinograms were used, thereby supporting market growth. However, the high cost of electroretinography procedures and risks associated with the device is expected to hamper the market growth in the coming years.